# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000059478-23-000122
Filing Date
2023-03-17
Accepted
2023-03-17 16:26:21
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | llydefa14a2023_additionalm.htm | DEFA14A | 12934
2 |  | proxynoticefinal-elilillyad.jpg | GRAPHIC | 612214
3 |  | proxynoticefinal-elilillyae.jpg | GRAPHIC | 503767
4 |  | proxynoticefinal-elilillyaf.jpg | GRAPHIC | 612216
5 |  | proxynoticefinal-elilillyag.jpg | GRAPHIC | 498360
| Complete submission text file | 0000059478-23-000122.txt |  | 3079486

Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06351 | Film No.: 23742988
SIC: 2834 Pharmaceutical Preparations